Hemovigilance: An Effective Tool for Improving Transfusion Safety

Description

* Hemovigilance is a "quality process" which aims to improve quality and increase safety of blood transfusion, by surveying all activities of the blood transfusion chain, from donors to recipients.Hemovigilance programmes have now been in existence for over 15 years, but many countries and centers are still at the development stage. This valuable resource brings together the main elements of such programmes and shows the different types of models available. A general introduction includes Chapters on hemovigilance as a quality tool for transfusion as well as concepts of and models for hemovigilance. The core of the book describes how Hemovigilance systems have been set up and how they work in hospitals, blood establishments, and at a national level. These Chapters are written according to a structured template: products and processes, documentation of jobs, monitoring and assessment, implementation and evaluation of measures for improvement, education and training.  Chapters on Hemovigilance at the International level, Achievements and new developments complete the picture.Hemovigilance is above all a practical guide to setting up and improving hemovigilance systems, whilst raising awareness for reporting adverse events and reactions.This is the first international book on hemovigilance, assembling all the vital issues in one definitive reference source - essential reading for all staff involved in the transfusion process.Content: Chapter 1 Introduction (pages 1–4): Rene R. P. de VriesChapter 2 Hemovigilance: A Quality Tool for the Blood Transfusion Chain (pages 5–11): Rene R. P. de VriesChapter 3 Concepts and Models (pages 12–16): Rene R. P. de Vries and Jean?Claude FaberChapter 4 Setting Up or Consolidating a System for Donor Hemovigilance at the Level of a Blood Establishment (pages 17–35): Johanna Wiersum?Osselton, Wim de Kort, Tanneke Marijt?Van der Kreek and Jeroen de WitChapter 5 Preparation of Blood Components (pages 36–51): Tomislav VukChapter 6 Establishment of Hemovigilance for the Testing, Storage, Distribution, Transport, and Issuing of Blood and Blood Components: The Example of Greece (pages 52–60): Constantina PolitisChapter 7 Medical Decision, Ordering, Administration of Component, and Monitoring of the Patient (pages 61–73): Mickey B.C. Koh, Ramir Alcantara, Mark Grumbridge and Ai Leen AngChapter 8 Blood Donation: An Approach to Donor Vigilance (pages 75–98): Peter Tomasulo, Madhav Erraguntla and Hany KamelChapter 9 Preparation of Blood Components (pages 99–112): Erhard Seifried, Reinhard Henschler, Juergen Luhm, Thea Mueller?Kuller, Hans?Ulrich Pfeiffer, Walid Sireis and Markus M. MuellerChapter 10 Testing, Issuing, and Transport of Blood Components (pages 113–125): Constantina PolitisChapter 11 Clinical Activities: Medical Decision?making, Sampling, Ordering Components, Administration, and Patient Monitoring (pages 126–143): Clare TaylorChapter 12 The French Hemovigilance Network: From the Blood Scandal to Epidemiologic Surveillance of the Transfusion Chain (pages 145–158): Philippe RenaudierChapter 13 The Japanese Hemovigilance System (pages 159–167): Hitoshi Okazaki, Naoko Goto, Shun?Ya Momose, Satoru Hino and Kenji TadokoroChapter 14 Setting up a National Hemovigilance System: SHOT (pages 168–179): Hannah Cohen and Lorna M. WilliamsonChapter 15 The Dutch Hemovigilance System: Transfusion Reactions in Patients (TRIP) (pages 180–190): Martin R. Schipperus, Johanna Wiersum?Osselton, Pauline Y. Zijlker?Jansen and Anita J. W. van Tilborgh?De JongChapter 16 Regulatory, Public Health, and International Aspects of Hemovigilance in Canada (pages 191–203): Peter R. Ganz and Jun WuChapter 17 Setting up and Implementation of the National Hemovigilance System in Italy (pages 204–208): Giuliano Grazzini and Simonetta PupellaChapter 18 The Australian Hemovigilance System (pages 209–219): Erica M. Wood, Lisa J. Stevenson, Simon A. Brown and Christopher J. HoganChapter 19 Biovigilance in the United States (pages 220–225): D. Michael Strong, Barbee Whitaker, Matthew J. Kuehnert and Jerry A. HolmbergChapter 20 Arab Hemovigilance Network (pages 226–232): Salwa Hindawi, Magdy Elekiaby and Gamal GabraChapter 21 Hemovigilance in the European Community (pages 233–252): Jean?Claude FaberChapter 22 International Collaboration (pages 253–259): Paul F.W. StrengersChapter 23 Hemovigilance in Developing Countries (pages 260–277): Jean?Claude FaberChapter 24 Achievements Through Hemovigilance (pages 279–301): Jean?Claude Faber and Fatima NascimentoChapter 25 Vigilance of Alternatives for Blood Components (pages 303–321): Dafydd ThomasChapter 26 Surveillance of Clinical Effectiveness of Transfusion (pages 322–325): Brian McClelland and Katherine ForresterChapter 27 Biovigilance (pages 326–340): Jerry A. Holmberg, Matthew J. Kuehnert and D. Michael Strong